Doctors

Plagues Upon the Earth: How Wealth Intersects With Mortality

Kyle Harper’s new book, Plagues Upon the Earth: Disease and the Course of Human History, shows that the story of disease is...

Paid to Show the Drug Works: Why “Blind” Clinical Trials for New Drugs are Far Less Blind Than They Should Be

New research shows that physicians in industry-sponsored trials are more captured by pharmaceutical companies than physicians in unsponsored ones.

From Most No-Brainer to Most Complicated: A List of Policy Proposals to Mitigate the Virus’ Impact

Policymakers need to figure out which sectors we wish to keep up and running (food, health care), which sectors we want to contract rapidly...

The Amazon of Health Care: How CVS Is Evolving From a Drug Store Chain into a Tech Platform

CVS is built on a dominant chain of drug stores, but it is now trying to turn itself into a "uniquely powerful platform" for...

Hospital Mergers: The Forgotten Problem of American Health Care

In the US, there are more than 100 hospital mergers every year. This increasing concentration does not lead to the promised savings, nor to...

When Medical Experiments Serve the Business Needs of Pharmaceutical Firms Instead of Science

The first part of a two-part interview with Daniel Goldstein, MD, an oncologist who also studies the influence of business interests on healthcare—from treating patients...

LATEST NEWS

The Convoluted Regulatory Regime for M&A Assessments in the US

What happens when the goals of antitrust enforcers clash with regulators focused on issues of national security and public interest? A forthcoming book by Ioannis Kokkoris, Public Interest Considerations in US Merger Control, explores these tensions in the United States regulatory framework.

Was Microsoft’s “Polluted Java” a presumptively legal improved product design?

Section 2 defendants often interpret the holdings of the United States Court of Appeals for the District of Columbia in U.S. v...

Income Inequality May Worsen the Spread of Infectious Disease

Income inequality may exacerbate the spread of infectious diseases. In a new paper, Jay Bhattacharya, Joydeep Bhattacharya, and Min Kyong Kim examine the relationship between income inequality and the incidence and prevalence of tuberculosis across countries.

The Classic Theory of Albert O. Hirschman Argues Against the US Chamber’s Case for Non-Competes

Drawing on the theory of Albert O. Hirschman’s  Exit, Voice, and Loyalty, Brian Callaci argues non-compete clauses stifle the important channels of communication between employees and businesses necessary for improving firm competitiveness. The evidence also shows that, despite claims from businesses, non-competes harm rather than reward employees for their loyalty. 

AI For the Antitrust Regulator

Cary Coglianese lays out the potential, and the considerations, for antitrust regulators to use machine learning and artificial intelligence algorithms.